SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,732,784 | +13.6% | 22,544 | +7.3% | 0.02% | +15.0% |
| Q2 2023 | $2,405,607 | -23.8% | 21,006 | -8.2% | 0.02% | -28.6% |
| Q1 2023 | $3,155,067 | +9.5% | 22,891 | +2.9% | 0.03% | 0.0% |
| Q4 2022 | $2,881,730 | +15.4% | 22,239 | -1.5% | 0.03% | +7.7% |
| Q3 2022 | $2,497,000 | +48.6% | 22,589 | +0.8% | 0.03% | +62.5% |
| Q2 2022 | $1,680,000 | -3.8% | 22,418 | +0.3% | 0.02% | +14.3% |
| Q1 2022 | $1,747,000 | -5.0% | 22,361 | +9.5% | 0.01% | 0.0% |
| Q4 2021 | $1,838,000 | -3.7% | 20,415 | -1.1% | 0.01% | -12.5% |
| Q3 2021 | $1,909,000 | +19.8% | 20,643 | +0.7% | 0.02% | +23.1% |
| Q2 2021 | $1,594,000 | -1.1% | 20,509 | -5.1% | 0.01% | -7.1% |
| Q1 2021 | $1,611,000 | -55.8% | 21,615 | +1.1% | 0.01% | -57.6% |
| Q4 2020 | $3,646,000 | +15.2% | 21,386 | -5.1% | 0.03% | +6.5% |
| Q3 2020 | $3,166,000 | +14.7% | 22,543 | +31.0% | 0.03% | -20.5% |
| Q2 2020 | $2,760,000 | +64.5% | 17,211 | +0.3% | 0.04% | +34.5% |
| Q1 2020 | $1,678,000 | – | 17,154 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |